2, Figure S9: The HR-MS spectrum of M-3, Figure S10: The HPLC2, Figure S9: The

August 26, 2022

2, Figure S9: The HR-MS spectrum of M-3, Figure S10: The HPLC
2, Figure S9: The HR-MS spectrum of M-3, Figure S10: The HPLC spectrum of M-1 below 254 nm and 485 nm, Figure S11: The HPLC spectrum of M-2 under 254 nm and 495 nm, Figure S12: The HPLC spectrum of M-3 under 254 nm and 500 nm, Figure S13: UV absorption spectrum of 50uM M-1 and M-2 in distinct solvent, Figure S14: Fluorescence emission spectrum of 50 uM M-1 and M-2 in diverse solvent, Figure S15: The fluorescence decays of M-1 and M-2 in different solvent, Table S1: M-1 spectrum data, Table S2: M-2 spectrum data, Table S3: M-1 typical lifetime in various solvents, Table S4: M-2 typical lifetime in unique solvents, Table S5: M-3 average lifetime in distinctive solvents, Table S6: M-1 3 typical lifetime in BSA, Table S7: M-3 average lifetime in PEG. Table S8: The xyz coordinates on the optimized geometry at B3LYP/631g(d,p)-IEFPCM(water) level of all molecules in both ground (GS) and first excited states (ES). Author Contributions: Conceptualization, S.W., S.Z., M.M. and W.L.; Information curation, S.W. and S.Z.; Formal analysis, S.W., Y.Z., Y.T., C.L.; Writing–original draft, S.W. and S.Z.; Writing–review and editing, S.W., S.Z., M.M. and W.L. All authors have study and agreed to the published version with the manuscript. Funding: This analysis was funded by the State Crucial Laboratory of Fine Chemical compounds, Dalian University of Technology, grant number KF1913, the Basic Analysis Funds for the Central Universities and National Organic Science Foundation of China, grant number 82104000. Institutional Review Board PSB-603 web Statement: No applicable. Informed Consent Statement: No applicable. Information Availability Statement: Information is contained within the report or Supplementary Components. Acknowledgments: Frontier orbital calculation within this operate was supported by the Science and Technology Analysis Project of Hubei Province Division of Education (D20191001), Hubei University. Conflicts of Interest: The authors declare no conflict of interest. Sample Availability: Samples on the compounds will not be available from the authors.
Combretastatin A-1 Technical Information moleculesReviewAntiviral Therapeutic Possible of Curcumin: An UpdateAbdollah Ardebili 1,two, , Mohammad Hassan Pouriayevali 3, , Sahar Aleshikh 2 , Marziyeh Zahani 4 , Mehdi Ajorloo five,six , Ahdieh Izanloo 7 , Abolghasem Siyadatpanah 8 , Hadi Razavi Nikoo two,9, , Polrat Wilairatana 10, and Henrique Douglas Melo Coutinho 11, 6Citation: Ardebili, A.; Pouriayevali, M.H.; Aleshikh, S.; Zahani, M.; Ajorloo, M.; Izanloo, A.; Siyadatpanah, A.; Razavi Nikoo, H.; Wilairatana, P.; Coutinho, H.D.M. Antiviral Therapeutic Potential of Curcumin: An Update. Molecules 2021, 26, 6994. https://doi.org/ ten.3390/molecules26226994 Academic Editors: Francesca Mancianti and Valentina Virginia Ebani Received: 30 September 2021 Accepted: 16 November 2021 Published: 19 NovemberLaboratory Sciences Study Center, Golestan University of Healthcare Sciences, Gorgan 4934174515, Iran; [email protected] Division of Microbiology, Faculty of Medicine, Golestan University of Healthcare Sciences, Gorgan 4934174515, Iran; [email protected] Department of Arboviruses and Viral Hemorrhagic Fevers (National Ref Lab), Pasteur Institute of Iran, Tehran 1316943551, Iran; [email protected] Student Investigation Committee, Faculty of Paramedicine, Golestan University of Health-related Sciences, Gorgan 4934174515, Iran; [email protected] Hepatitis Study Center, Lorestan University of Healthcare Sciences, Khorramabad 6813833946, Iran; [email protected] Department of Virolog.